Australia markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
301.02-2.76 (-0.91%)
At close: 04:00PM EST
302.45 +1.43 (+0.48%)
After hours: 06:54PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
3,273,200
2,342,100
2,711,647
1,176,810
Depreciation & amortisation
143,700
125,600
109,515
106,941
Deferred income taxes
-465,900
-154,600
277,341
167,387
Stock-based compensation
498,400
441,400
429,461
360,489
Change in working capital
566,300
-105,200
-54,454
-66,101
Accounts receivable
-412,300
-274,700
-223,444
-225,587
Inventory
-85,100
-92,800
-132,014
-64,047
Accounts payable
14,800
31,900
51,276
-22,785
Other working capital
3,813,600
2,408,500
2,993,707
1,493,879
Other non-cash items
-100,200
11,300
91,932
21,401
Net cash provided by operating activities
4,046,500
2,643,500
3,253,505
1,569,330
Cash flows from investing activities
Investments in property, plant and equipment
-232,900
-235,000
-259,798
-75,451
Acquisitions, net
-295,900
0
-
-1,154,212
Purchases of investments
-585,000
-605,200
-450,723
-576,515
Sales/maturities of investments
483,100
499,300
809,909
570,860
Net cash used for investing activities
-630,700
-340,900
99,388
-1,235,318
Cash flows from financing activities
Debt repayment
-87,500
-47,000
-42,275
-39,185
Common stock issued
-
-
-
343,244
Common stock repurchased
-539,800
-1,561,300
-739,407
-192,015
Other financing activities
3,800
5,700
-1,796
4,683
Net cash used provided by (used for) financing activities
-444,100
-1,478,000
-505,281
126,773
Net change in cash
2,896,800
811,200
2,868,164
462,428
Cash at beginning of period
6,280,200
5,988,900
3,120,681
2,658,253
Cash at end of period
9,251,900
6,800,100
5,988,845
3,120,681
Free cash flow
Operating cash flow
4,046,500
2,643,500
3,253,505
1,569,330
Capital expenditure
-232,900
-235,000
-259,798
-75,451
Free cash flow
3,813,600
2,408,500
2,993,707
1,493,879